INVO Fertility, Inc. (IVF) stock
IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.60−0.08 (-3.17%)
Close on Nov 13, 2026Market cap $6.52MP/E –Yield –
INVO Fertility ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
INVO Fertility's ebitda for the twelve months ending Jun 30, 2026 was -$5.37M. For fiscal 2025 it was -$6.56M. The highest annual figure on record is -$540.79K in fiscal 2012.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.56M | – |
| FY2024 | Dec 31, 2024 | -$5.71M | – |
| FY2023 | Dec 31, 2023 | -$6.57M | – |
| FY2022 | Dec 31, 2022 | -$10.55M | – |
| FY2021 | Dec 31, 2021 | -$5.19M | – |
| FY2020 | Dec 31, 2020 | -$5.50M | – |
| FY2019 | Dec 31, 2019 | -$1.78M | – |
| FY2018 | Dec 31, 2018 | -$2.63M | – |
| FY2017 | Dec 31, 2017 | -$637.61K | – |
| FY2016 | Dec 31, 2016 | -$2.11M | – |
| FY2015 | Dec 31, 2015 | -$589.44K | – |
| FY2014 | Dec 31, 2014 | -$1.67M | – |
| FY2013 | Dec 31, 2013 | -$593.72K | – |
| FY2012 | Dec 31, 2012 | -$540.79K | – |
| FY2011 | Dec 31, 2011 | -$681.77K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.14M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.45M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.28M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.50M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.73M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.07M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.62M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.28M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.37M | – |
| Q3 FY2023 | Sep 30, 2023 | -$865.79K | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.05M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.29M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.70M | -631.6% |
| Q3 FY2022 | Sep 30, 2022 | -$2.51M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.66M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.69M | – |
| Q4 FY2021 | Dec 31, 2021 | $507.64K | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.26M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.88M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.56M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.78M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.27M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.06M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.39M | – |
| Q4 FY2019 | Dec 31, 2019 | -$737.16K | – |
| Q3 FY2019 | Sep 30, 2019 | -$628.70K | – |
| Q2 FY2019 | Jun 30, 2019 | -$64.30K | – |
| Q1 FY2019 | Mar 31, 2019 | -$347.14K | – |
| Q4 FY2018 | Dec 31, 2018 | -$511.92K | – |
| Q3 FY2018 | Sep 30, 2018 | -$188.49K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.79M | – |
| Q1 FY2018 | Mar 31, 2018 | -$139.15K | – |
| Q4 FY2017 | Dec 31, 2017 | -$195.63K | – |
| Q3 FY2017 | Sep 30, 2017 | -$142.87K | – |
| Q2 FY2017 | Jun 30, 2017 | -$132.41K | – |
| Q1 FY2017 | Mar 31, 2017 | -$166.70K | – |
| Q4 FY2016 | Dec 31, 2016 | -$270.30K | – |
| Q3 FY2016 | Sep 30, 2016 | -$207.37K | – |
| Q2 FY2016 | Jun 30, 2016 | -$1.45M | – |
See a number that looks wrong?